
    
      This is a Phase III, parallel-arm, open-label continuation of the PROUD-PV study performed in
      adults diagnosed with Polycythemia Vera (PV). Patients who received AOP2014 in the primary
      study, PROUD-PV will continue on AOP2014, patients who received HU in the PROUD-PV study will
      receive best available therapy as selected by the investigator. Only patients who completed
      PROUD-PV including the end of study visit will be enrolled into this continuation study.
    
  